Zoya Qaiyum
60 Leonard Avenue, 5, KD-408
Toronto, ON, Canada
Toronto, ON, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Response to Correspondence on 'Why the term nr-axSpA should not be used for diagnosis'.
Journal: Annals of the rheumatic diseases
Published: December 05, 2024
Effect of Integrin Blockade on Experimental Spondyloarthritis.
Journal: Biomolecules
Published: September 19, 2024
Cardiac valve immune profiling in non-radiographic axial spondyloarthritis.
Journal: Annals of the rheumatic diseases
Published: April 08, 2024
Enhanced Type 1 Interferon Signature in Axial Spondyloarthritis Patients Unresponsive to Secukinumab Treatment.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: February 28, 2024
Differential Effects of Integrin Blockade on Gut and Sacroiliac Joint Inflammation.
Journal: The Journal of rheumatology
Published: May 15, 2023
Proteomic and genomic profiling of plasma exosomes from patients with ankylosing spondylitis.
Journal: Annals of the rheumatic diseases
Published: January 11, 2023
The gut-joint axis in spondyloarthritis: immunological, microbial, and clinical insights.
Journal: Seminars in immunopathology
Published: August 10, 2020
Response to: 'Gut-derived CD8+ tissue-resident memory T cells are expanded in the peripheral blood and synovia of SpA patients' by Guggino et al.
Journal: Annals of the rheumatic diseases
Published: November 19, 2019
Integrin and transcriptomic profiles identify a distinctive synovial CD8+ T cell subpopulation in spondyloarthritis.
Journal: Annals of the rheumatic diseases
Published: March 07, 2019
Altered Cytotoxicity Profile of CD8+ T Cells in Ankylosing Spondylitis.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: January 25, 2019
TYK2 inhibition reduces type 3 immunity and modifies disease progression in murine spondyloarthritis.
Journal: The Journal of clinical investigation
Published: December 03, 2018
Last Updated: 09/26/2026